Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04268160

GPx Activity in Subjects With Aortic Stenosis Undergoing TAVR

Glutathione Peroxidase Activity in Subjects With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this project is to investigate the association of glutathione peroxidase (GPx) and severe aortic stenosis (AS), as well as the impact of transcatheter aortic valve replacement (TAVR) on GPx activity post-procedure. The burden of oxidative stress will be determined by the measurement of GPx, superoxide dismutase (SOD) and lipoprotein A (Lp(a)). We hypothesize GPx activity is reduced in participants with severe AS vs control groups and GPx activity is to increase after TAVR is performed.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBlood draw to measure GPx activityRoutine blood draw to measure levels of blood markers.
DIAGNOSTIC_TESTBlood draw to measure SOD activityRoutine blood draw to measure levels of blood markers.
DIAGNOSTIC_TESTBlood draw to measure Lp(a) levelsRoutine blood draw to measure levels of blood markers.

Timeline

Start date
2020-11-01
Primary completion
2021-06-15
Completion
2021-06-15
First posted
2020-02-13
Last updated
2021-06-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04268160. Inclusion in this directory is not an endorsement.